Musa, A.; Mostafa, E.M.; Bukhari, S.N.A.; Alotaibi, N.H.; El-Ghorab, A.H.; Farouk, A.; Nayl, A.A.; Ghoneim, M.M.; Abdelgawad, M.A.
EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones. Molecules 2022, 27, 1158.
https://doi.org/10.3390/molecules27041158
AMA Style
Musa A, Mostafa EM, Bukhari SNA, Alotaibi NH, El-Ghorab AH, Farouk A, Nayl AA, Ghoneim MM, Abdelgawad MA.
EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones. Molecules. 2022; 27(4):1158.
https://doi.org/10.3390/molecules27041158
Chicago/Turabian Style
Musa, Arafa, Ehab M. Mostafa, Syed Nasir Abbas Bukhari, Nasser Hadal Alotaibi, Ahmed H. El-Ghorab, Amr Farouk, AbdElAziz A. Nayl, Mohammed M. Ghoneim, and Mohamed A. Abdelgawad.
2022. "EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones" Molecules 27, no. 4: 1158.
https://doi.org/10.3390/molecules27041158
APA Style
Musa, A., Mostafa, E. M., Bukhari, S. N. A., Alotaibi, N. H., El-Ghorab, A. H., Farouk, A., Nayl, A. A., Ghoneim, M. M., & Abdelgawad, M. A.
(2022). EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones. Molecules, 27(4), 1158.
https://doi.org/10.3390/molecules27041158